To say that the understanding of GE technology is clear is arrogant. It is a complex challenge to understand the risks, performance, and costs of new developments, such as CRISPR. Market excitement, accompanied by profitable patents grab supersedes precaution and a thorough understanding of what is at stake is ignored or discarded. The argument of “safety” remains murky in the case of many GE crop technologies. Read more.